Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Leukemia and Lymphoma

• Publication date

  2015-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428194.2014.1001985PMID 25563559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 Cases

  2014cited by this paper
• Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.

  2014cited by this paper
• High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.

  2014cited by this paper
• Human T follicular helper (Tfh) cells and disease

  2014cited by this paper
• Clinical Significance of sIL-2R Levels in B-Cell Lymphomas

  2013cited by this paper
• Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

  2013cited by this paper
• Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

  2012cited by this paper
• Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.

  2012cited by this paper
• Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

  2012cited by this paper
• Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens

  2012cited by this paper
• Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

  2012cited by this paper
• Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T‐cell lymphoma (AITL)

  2010cited by this paper
• Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma

  2010cited by this paper
• Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.

  2010cited by this paper
• Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

  2010cited by this paper
• Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

  2009cited by this paper
• Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.

  2009cited by this paper
• PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

  2009cited by this paper
• Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

  2008cited by this paper
• International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

  2008cited by this paper
• High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

  2008cited by this paper
• The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

  2007cited by this paper
• Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index

  2005cited by this paper
• Gene Expression Profile

  2004cited by this paper
• Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.

  2004cited by this paper
• Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

  2003cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• The soluble interleukin-2 receptor: biology, function, and clinical application.

  1990cited by this paper

• Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein–Barr virus infection patients in Japan

  2022cites this paper
• Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy

  2019cites this paper
• Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP

  2018cites this paper
• Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?

  2017cites this paper
• Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma

  2017cites this paper
• Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

  2016cites this paper
• Comprehensive serum cytokine analysis identi fi es IL-1RA and soluble IL-2R α as predictors of event-free survival in T-cell lymphoma

  2015cites this paper